Cytogel Pharma, LLC research brief

CIK 1491841 Copy CIK

Generated Nov. 13, 2026, 6:17 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: DARIEN Connecticut. Reported legal jurisdiction: CONNECTICUT. These do not establish investor residence or where funds were deployed.

• March 26, 2026 · D/A · 0001213900-26-034790 · Source evidence

  Reported offering amount: 16000000 USD. Reported amount sold: 0 USD.

• Dec. 23, 2025 · D/A · 0001213900-25-125022 · Source evidence

  Reported offering amount: 1000000 USD. Reported amount sold: 250000 USD.

• Dec. 23, 2025 · D · 0001213900-25-124742 · Source evidence

  Reported offering amount: 16000000 USD. Reported amount sold: 0 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Cytogel Pharma, LLC research brief,” CIK 1491841, retrieved Nov. 13, 2026, 6:17 p.m.. Cite the specific accessions used. No amounts have been summed.